Company: GRCE
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001140361-25-030398
Chunk: 42

Company: Grace Therapeutics, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Item 8
Chunk 42
---
4192
    
      us-gaap:RetainedEarningsMember

    2024-04-01
    2024-06-30

    0001444192
    
      us-gaap:CommonStockMember

    2024-06-30

    0001444192
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-06-30

    0001444192
    
      us-gaap:AccumulatedOtherComprehensiveIncomeMember

    2024-06-30

    0001444192
    
      us-gaap:RetainedEarningsMember

    2024-06-30

    0001444192

    2024-06-30

    0001444192

    2025-02-11
    2025-02-11

    0001444192
    
      grce:TreasuryBillsClassifiedAsCashEquivalentsMember
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001444192
    
      grce:TreasuryBillsClassifiedAsCashEquivalentsMember
      us-gaap:FairValueInputsLevel1Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001444192
    
      grce:TreasuryBillsClassifiedAsCashEquivalentsMember
      us-gaap:FairValueInputsLevel2Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001444192
    
      grce:TreasuryBillsClassifiedAsCashEquivalentsMember
      us-gaap:FairValueInputsLevel3Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001444192
    
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001444192
    
      us-gaap:FairValueInputsLevel1Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001444192
    
      us-gaap:FairValueInputsLevel2Member
      us-gaap